A group of academics from India, Qatar and the United Kingdom recently published a worrying new study in the Journal of Pharmaceutical Policy and Practice (2023, 16:39) on the volume of unapproved and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results